Amylin and hypertension: the status of the current debate Dear Sir, In response to a letter from Drs Young, Kolterman and Hall [1] published in your journal recently, we would like to emphasise the following points on a possible role for amylin in essential hypertension.
The role of amylin as a renal growth factor [7] could also be particularly relevant. What are its long-term effects? Do its actions lead to renal remodelling which is known to be important in the development of hypertension? Preliminary data from our group suggest renal ultrastructural abnormalities in the amylin gene-deletion mouse [8] .
A negative response to alterations in blood pressure after short-term infusion of peptides does not in itself provide evidence, one way or the other, for the involvement of the corresponding hormonal system in the development of hypertension. We view the issues raised above to be important when considering the possible involvement of components of the amylin system in diseases such as hypertension.
Yours sincerely, P. Wookey and M. Cooper
